cached image

Thomas Richard Kosten, M.D. - Publications

Affiliations: 
Psychiatry Baylor College of Medicine, Houston, TX 
Area:
Addiction Neuroscience
Website:
http://neuro.bcm.edu/?sct=gfaculty&prf=41

279 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Holst M, Mathai DS, Patel MM, Rodgman C, Keller J, Hussain MZ, De La Garza R, Kosten TR, Verrico CD. Use of Guanfacine for Cannabis use Disorder and Related Symptomology. The American Journal On Addictions. PMID 31483544 DOI: 10.1111/ajad.12959  0.68
2019 Kampangkaew JP, Spellicy CJ, Nielsen EM, Harding MJ, Ye A, Hamon SC, Kosten TR, Nielsen DA. Pharmacogenetic role of dopamine transporter (SLC6A3) variation on response to disulfiram treatment for cocaine addiction. The American Journal On Addictions. PMID 31087723 DOI: 10.1111/ajad.12891  0.48
2019 Deng H, Desai PV, Mohite S, Okusaga OO, Zhang XY, Nielsen DA, Kosten TR. Hospital Stay in Synthetic Cannabinoid Users With Bipolar Disorder, Schizophrenia, or Other Psychotic Disorders Compared With Cannabis Users. Journal of Studies On Alcohol and Drugs. 80: 230-235. PMID 31014468  0.48
2019 Arora R, Haile CN, Kosten TA, Wu Y, Ramakrishnan M, Hawkins LD, Orson FM, Kosten TR. Preclinical efficacy of an anti-methamphetamine vaccine using E6020 adjuvant. The American Journal On Addictions. PMID 30701618 DOI: 10.1111/ajad.12867  0.6
2018 Curtis K, Stewart CJ, Robinson M, Molfese DL, Gosnell SN, Kosten TR, Petrosino JF, De La Garza R, Salas R. Insular Resting State Functional Connectivity is Associated with Gut Microbiota Diversity. The European Journal of Neuroscience. PMID 30554441 DOI: 10.1111/ejn.14305  0.6
2018 Patel MM, Nielsen DA, Kosten TR, De La Garza R, Newton TF, Verrico CD. FAAH variant Pro129Thr modulates subjective effects produced by cocaine administration. The American Journal On Addictions. PMID 30126012 DOI: 10.1111/ajad.12788  0.68
2018 Deng H, Verrico CD, Kosten TR, Nielsen DA. Psychosis and synthetic cannabinoids. Psychiatry Research. 268: 400-412. PMID 30125871 DOI: 10.1016/j.psychres.2018.08.012  0.68
2018 Kosten TR, Graham DP, Nielsen DA. Opioid Use Disorder After Self-medicating Pain From Traumatic Brain Injury. Jama Psychiatry. PMID 29710138 DOI: 10.1001/jamapsychiatry.2018.0098  0.48
2018 Kosten TR, Graham DP, Nielsen DA. Neurobiology of Opioid Use Disorder and Comorbid Traumatic Brain Injury. Jama Psychiatry. PMID 29710079 DOI: 10.1001/jamapsychiatry.2018.0101  0.48
2018 Zhang X, Nielsen DA, Domingo CB, Shorter DI, Nielsen EM, Kosten TR. Pharmacogenetics of Dopamine β-Hydroxylase in cocaine dependence therapy with doxazosin. Addiction Biology. PMID 29498170 DOI: 10.1111/adb.12611  0.48
2018 Yammine L, Kosten TR, Cinciripini PM, Green CE, Meininger JC, Minnix JA, Newton TF. Exenatide once weekly for smoking cessation: study protocol for a randomized clinical trial. Medicine. 97: e9567. PMID 29480848 DOI: 10.1097/MD.0000000000009567  0.6
2017 Heekin RD, Shorter D, Kosten TR. Current status and future prospects for the development of substance abuse vaccines. Expert Review of Vaccines. 16: 1067-1077. PMID 28918668 DOI: 10.1080/14760584.2017.1378577  0.68
2017 Curtis K, Viswanath H, Velasquez KM, Molfese DL, Harding MJ, Aramayo E, Baldwin PR, Ambrosi E, Madan A, Patriquin M, Frueh BC, Fowler JC, Kosten TR, Nielsen DA, Salas R. Increased habenular connectivity in opioid users is associated with an α5 subunit nicotinic receptor genetic variant. The American Journal On Addictions. PMID 28857330 DOI: 10.1111/ajad.12607  0.52
2017 Mathai DS, Holst M, Rodgman C, Haile CN, Keller J, Hussain MZ, Kosten TR, Newton TF, Verrico CD. Guanfacine Attenuates Adverse Effects of Dronabinol (THC) on Working Memory in Adolescent-Onset Heavy Cannabis Users: A Pilot Study. The Journal of Neuropsychiatry and Clinical Neurosciences. appineuropsych161203. PMID 28641496 DOI: 10.1176/appi.neuropsych.16120328  0.68
2016 Mathai DS, Verrico CD, Shorter D, Coverdale JH, Kosten TR. "Just one bad high:" considering synthetic cannabinoid outcome expectancies in adolescents. The American Journal On Addictions. PMID 27749024 DOI: 10.1111/ajad.12457  0.68
2016 Ayanga D, Shorter D, Kosten TR. Update on Pharmacotherapy for Treatment of Opioid Use Disorder. Expert Opinion On Pharmacotherapy. PMID 27734745 DOI: 10.1080/14656566.2016.1244529  0.68
2016 Shorter D, Nielsen DA, Hamon SC, Nielsen EM, Kosten TR, Newton TF, De La Garza R. The α-1 adrenoceptor (ADRA1A) genotype moderates the magnitude of acute cocaine-induced subjective effects in cocaine-dependent individuals. Pharmacogenetics and Genomics. PMID 27379509 DOI: 10.1097/FPC.0000000000000234  0.6
2016 Verrico CD, Haile CN, De La Garza R, Grasing K, Kosten TR, Newton TF. Subjective and Cardiovascular Effects of Intravenous Methamphetamine during Perindopril Maintenance: A Randomized, Double-Blind, Placebo-Controlled Human Laboratory Study. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). PMID 27207905 DOI: 10.1093/ijnp/pyw029  0.68
2016 Li X, Shorter D, Kosten TR. Buprenorphine Prescribing: To Expand or Not to Expand. Journal of Psychiatric Practice. 22: 183-192. PMID 27123798 DOI: 10.1097/PRA.0000000000000154  0.6
2016 An HM, Tan YL, Tan SP, Shi J, Wang ZR, Yang FD, Huang XF, Soars JC, Kosten TR, Zhang XY. Smoking and Serum Lipid Profiles in Schizophrenia. Neuroscience Bulletin. PMID 27017941 DOI: 10.1007/s12264-016-0022-0  0.48
2016 Zhang XY, Tan YL, Chen DC, Tan SP, Malouta MZ, Bernard JD, Combs JL, Bhatti S, Davis MC, Kosten TR, Soares JC. Serum IL-18 level, clinical symptoms and IL-18-607A/C polymorphism among chronic patients with schizophrenia in a Chinese Han population. Psychoneuroendocrinology. 68: 140-147. PMID 26974498 DOI: 10.1016/j.psyneuen.2016.03.002  0.44
2016 Xiu MH, Tian L, Chen S, Tan YL, Chen DC, Chen J, Chen N, De Yang F, Licinio J, Kosten TR, Soares JC, Zhang XY. Contribution of IL-10 and its -592 A/C polymorphism to cognitive functions in first-episode drug-naive schizophrenia. Brain, Behavior, and Immunity. PMID 26971470 DOI: 10.1016/j.bbi.2016.03.005  0.6
2016 Deng H, Wang J, Zhang X, Ma M, Domingo C, Sun H, Kosten T. Smoking reduction and quality of life in chronic patients with schizophrenia in a Chinese population: A pilot study. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. PMID 26824336 DOI: 10.1111/ajad.12337  0.6
2015 Christodoulides N, De La Garza R, Simmons GW, McRae MP, Wong J, Newton TF, Kosten TR, Haque A, McDevitt JT. Next Generation Programmable Bio-Nano-Chip System for On-Site Detection in Oral Fluids. Journal of Drug Abuse. 1: 1-6. PMID 26925466  0.6
2015 Zhang XY, Fan FM, Chen DC, Tan YL, Tan SP, Hu K, Salas R, Kosten TR, Zunta-Soares G, Soares JC. Extensive white matter abnormalities and clinical symptoms in drug-naive patients with first-episode schizophrenia: a voxel-based diffusion tensor imaging study. The Journal of Clinical Psychiatry. PMID 26761708 DOI: 10.4088/JCP.14m09374  0.6
2015 Shorter D, Hsieh J, Kosten TR. Pharmacologic management of comorbid post-traumatic stress disorder and addictions. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. PMID 26587796 DOI: 10.1111/ajad.12306  0.68
2015 Haile CN, Kosten TA, Shen XY, O'Malley PW, Winoske KJ, Kinsey BM, Wu Y, Huang Z, Lykissa ED, Naidu N, Cox JA, Arora R, Kosten TR, Orson FM. Altered methamphetamine place conditioning in mice vaccinated with a succinyl-methamphetamine-tetanus-toxoid vaccine. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. PMID 26584468 DOI: 10.1111/ajad.12307  0.6
2015 Zhang XY, Tan YL, Chen DC, Tan SP, Yang FD, Wu HE, Zunta-Soares GB, Huang XF, Kosten TR, Soares JC. Interaction of BDNF with cytokines in chronic schizophrenia. Brain, Behavior, and Immunity. PMID 26407757 DOI: 10.1016/j.bbi.2015.09.014  0.44
2015 Newton TF, Haile CN, Mahoney JJ, Shah R, Verrico CD, De La Garza R, Kosten TR. Dopamine D3 receptor-preferring agonist enhances the subjective effects of cocaine in humans. Psychiatry Research. 230: 44-9. PMID 26239766 DOI: 10.1016/j.psychres.2015.07.073  0.68
2015 Ma L, Steinberg JL, Cunningham KA, Lane SD, Bjork JM, Neelakantan H, Price AE, Narayana PA, Kosten TR, Bechara A, Moeller FG. Inhibitory behavioral control: A stochastic dynamic causal modeling study comparing cocaine dependent subjects and controls. Neuroimage. Clinical. 7: 837-47. PMID 26082893 DOI: 10.1016/j.nicl.2015.03.015  0.48
2015 Christodoulides N, De La Garza R, Simmons GW, McRae MP, Wong J, Newton TF, Smith R, Mahoney Iii JJ, Hohenstein J, Gomez S, Floriano PN, Talavera H, Sloan DJ, Moody DE, Andrenyak DM, ... Kosten TR, et al. Application of programmable bio-nano-chip system for the quantitative detection of drugs of abuse in oral fluids. Drug and Alcohol Dependence. 153: 306-13. PMID 26048639 DOI: 10.1016/j.drugalcdep.2015.04.026  0.48
2015 Brewer AJ, Nielsen DA, Spellicy CJ, Hamon SC, Gingrich J, Thompson-Lake DG, Nielsen EM, Mahoney JJ, Kosten TR, Newton TF, De La Garza R. Genetic variation of the dopamine transporter (DAT1) influences the acute subjective responses to cocaine in volunteers with cocaine use disorders. Pharmacogenetics and Genomics. 25: 296-304. PMID 25850966 DOI: 10.1097/FPC.0000000000000137  0.4
2015 Kosten TR, Domingo CB. Editorial. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 24: 1. PMID 25823625 DOI: 10.1111/ajad.12212  0.6
2015 Cui Y, Robinson JD, Engelmann JM, Lam CY, Minnix JA, Karam-Hage M, Wetter DW, Dani JA, Kosten TR, Cinciripini PM. Reinforcement sensitivity underlying treatment-seeking smokers' affect, smoking reinforcement motives, and affective responses. Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors. 29: 300-11. PMID 25621416 DOI: 10.1037/adb0000050  0.52
2015 Li QQ, Sun CY, Luo YX, Xue YX, Meng SQ, Xu LZ, Chen N, Deng JH, Zhai HF, Kosten TR, Shi J, Lu L, Sun HQ. A conjugate vaccine attenuates morphine- and heroin-induced behavior in rats. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 18. PMID 25522425 DOI: 10.1093/ijnp/pyu093  0.48
2015 Thompson-Lake DG, Cooper KN, Mahoney JJ, Bordnick PS, Salas R, Kosten TR, Dani JA, De La Garza R. Withdrawal Symptoms and Nicotine Dependence Severity Predict Virtual Reality Craving in Cigarette-Deprived Smokers. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 17: 796-802. PMID 25475087 DOI: 10.1093/ntr/ntu245  0.52
2015 Shorter D, Domingo CB, Kosten TR. Emerging drugs for the treatment of cocaine use disorder: a review of neurobiological targets and pharmacotherapy. Expert Opinion On Emerging Drugs. 20: 15-29. PMID 25425416 DOI: 10.1517/14728214.2015.985203  0.48
2015 Ma L, Steinberg JL, Cunningham KA, Lane SD, Kramer LA, Narayana PA, Kosten TR, Bechara A, Moeller FG. Inhibitory behavioral control: a stochastic dynamic causal modeling study using network discovery analysis. Brain Connectivity. 5: 177-86. PMID 25336321 DOI: 10.1089/brain.2014.0275  0.48
2014 Kosten TA, Shen XY, Kinsey BM, Kosten TR, Orson FM. Attenuation of cocaine-induced locomotor activity in male and female mice by active immunization. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 23: 604-7. PMID 25251469 DOI: 10.1111/j.1521-0391.2014.12152.x  0.48
2014 Li X, Shorter D, Kosten TR. Buprenorphine in the treatment of opioid addiction: opportunities, challenges and strategies. Expert Opinion On Pharmacotherapy. 15: 2263-75. PMID 25171726 DOI: 10.1517/14656566.2014.955469  0.48
2014 Graham DP, Nielsen DA, Kosten TR, Davis LL, Hamner MB, Makotkine I, Yehuda R. Examining the utility of using genotype and functional biology in a clinical pharmacology trial: pilot testing dopamine β-hydroxylase, norepinephrine, and post-traumatic stress disorder. Psychiatric Genetics. 24: 181-2. PMID 24983834 DOI: 10.1097/YPG.0000000000000039  0.48
2014 Orson FM, Wang R, Brimijoin S, Kinsey BM, Singh RA, Ramakrishnan M, Wang HY, Kosten TR. The future potential for cocaine vaccines. Expert Opinion On Biological Therapy. 14: 1271-83. PMID 24835496 DOI: 10.1517/14712598.2014.920319  0.48
2014 Liu S, Green CE, Lane SD, Kosten TR, Moeller FG, Nielsen DA, Schmitz JM. The influence of dopamine β-hydroxylase gene polymorphism rs1611115 on levodopa/carbidopa treatment for cocaine dependence: a preliminary study. Pharmacogenetics and Genomics. 24: 370-3. PMID 24809448 DOI: 10.1097/FPC.0000000000000055  0.4
2014 Ramakrishnan M, Kinsey BM, Singh RA, Kosten TR, Orson FM. Hapten optimization for cocaine vaccine with improved cocaine recognition. Chemical Biology & Drug Design. 84: 354-63. PMID 24803171 DOI: 10.1111/cbdd.12326  0.48
2014 Kosten TR, Domingo CB, Shorter D, Orson F, Green C, Somoza E, Sekerka R, Levin FR, Mariani JJ, Stitzer M, Tompkins DA, Rotrosen J, Thakkar V, Smoak B, Kampman K. Vaccine for cocaine dependence: a randomized double-blind placebo-controlled efficacy trial. Drug and Alcohol Dependence. 140: 42-7. PMID 24793366 DOI: 10.1016/j.drugalcdep.2014.04.003  0.48
2014 Sun HQ, Chen HM, Yang FD, Lu L, Kosten TR. Epidemiological trends and the advances of treatments of amphetamine-type stimulants (ATS) in China. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 23: 313-7. PMID 24724890 DOI: 10.1111/j.1521-0391.2014.12116.x  0.48
2014 Spellicy CJ, Harding MJ, Hamon SC, Mahoney JJ, Reyes JA, Kosten TR, Newton TF, De La Garza R, Nielsen DA. A variant in ANKK1 modulates acute subjective effects of cocaine: a preliminary study. Genes, Brain, and Behavior. 13: 559-64. PMID 24528631 DOI: 10.1111/gbb.12121  0.4
2014 Schottenfeld RS, Chawarski MC, Cubells JF, George TP, Lappalainen J, Kosten TR. Randomized clinical trial of disulfiram for cocaine dependence or abuse during buprenorphine treatment. Drug and Alcohol Dependence. 136: 36-42. PMID 24462581 DOI: 10.1016/j.drugalcdep.2013.12.007  0.4
2014 Zhang XY, Chen da C, Xiu MH, Yang FD, Tan Y, Luo X, Zuo L, Kosten TA, Kosten TR. Cognitive function, plasma MnSOD activity, and MnSOD Ala-9Val polymorphism in patients with schizophrenia and normal controls. Schizophrenia Bulletin. 40: 592-601. PMID 23588476 DOI: 10.1093/schbul/sbt045  0.44
2014 Christodoulides N, De La Garza R, Simmons GW, McRae MP, Wong J, Kosten TR, Miller CS, Ebersole JL, McDevitt J. Programmable bio-nano-chip system for saliva diagnostics Proceedings of Spie - the International Society For Optical Engineering. 9112. DOI: 10.1117/12.2058726  0.4
2014 Newton TF, Haile CN, Mahoney JJ, Shah R, Verrico CD, De La Garza R, Kosten TR. Dopamine D3 receptor-preferring agonist enhances the subjective effects of cocaine in humans Psychiatry Research. DOI: 10.1016/j.psychres.2015.07.073  0.44
2013 Haile CN, Kosten TR. Pharmacotherapy for stimulant-related disorders. Current Psychiatry Reports. 15: 415. PMID 24142188 DOI: 10.1007/s11920-013-0415-y  0.48
2013 Sun HQ, Chen HM, Yang FD, Lu L, Kosten TR. Epidemiological trends and the advances of treatments of amphetamine-type stimulants (ATS) in China. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. PMID 24112143 DOI: 10.1111/j.1521-0391.2013.12116.x  0.48
2013 Verrico CD, Haile CN, Newton TF, Kosten TR, De La Garza R, De La Garza R. Pharmacotherapeutics for substance-use disorders: a focus on dopaminergic medications. Expert Opinion On Investigational Drugs. 22: 1549-68. PMID 24033127 DOI: 10.1517/13543784.2013.836488  0.48
2013 Nielsen DA, Hamon SC, Kosten TR. The κ-opioid receptor gene as a predictor of response in a cocaine vaccine clinical trial. Psychiatric Genetics. 23: 225-32. PMID 23995774 DOI: 10.1097/YPG.0000000000000008  0.4
2013 Shorter D, Nielsen DA, Huang W, Harding MJ, Hamon SC, Kosten TR. Pharmacogenetic randomized trial for cocaine abuse: disulfiram and α1A-adrenoceptor gene variation. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 1401-7. PMID 23849431 DOI: 10.1016/j.euroneuro.2013.05.014  0.4
2013 Han M, Huang XF, Chen da C, Xiu M, Kosten TR, Zhang XY. Diabetes and cognitive deficits in chronic schizophrenia: a case-control study. Plos One. 8: e66299. PMID 23840437 DOI: 10.1371/journal.pone.0066299  0.44
2013 Li W, Zhou N, Yu Q, Li X, Yu Y, Sun S, Kou C, Chen da C, Xiu MH, Kosten TR, Zhang XY. Association of BDNF gene polymorphisms with schizophrenia and clinical symptoms in a Chinese population. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 162: 538-45. PMID 23832605 DOI: 10.1002/ajmg.b.32183  0.44
2013 Wu JQ, Chen da C, Xiu MH, Tan YL, Yang FD, Kosten TR, Zhang XY. Tardive dyskinesia is associated with greater cognitive impairment in schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 46: 71-7. PMID 23827756 DOI: 10.1016/j.pnpbp.2013.06.013  0.44
2013 Zhang XY, Al Jurdi RK, Zoghbi AW, Chen da C, Xiu MH, Tan YL, Yang FD, Kosten TR. Prevalence, demographic and clinical correlates of suicide attempts in Chinese medicated chronic inpatients with schizophrenia. Journal of Psychiatric Research. 47: 1370-5. PMID 23791457 DOI: 10.1016/j.jpsychires.2013.05.024  0.6
2013 Kosten TA, Shen XY, O'Malley PW, Kinsey BM, Lykissa ED, Orson FM, Kosten TR. A morphine conjugate vaccine attenuates the behavioral effects of morphine in rats. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 45: 223-9. PMID 23739535 DOI: 10.1016/j.pnpbp.2013.05.012  0.48
2013 Hui L, Zhang X, Yu YQ, Han M, Huang XF, Chen da C, Wang ZR, Du WL, Kou CG, Yu Q, Kosten TR, Zhang XY. Association between DBH 19 bp insertion/deletion polymorphism and cognition in first-episode schizophrenic patients. Schizophrenia Research. 147: 236-40. PMID 23707643 DOI: 10.1016/j.schres.2013.04.035  0.44
2013 Krupitsky E, Zvartau E, Blokhina E, Verbitskaya E, Tsoy M, Wahlgren V, Burakov A, Masalov D, Romanova TN, Palatkin V, Tyurina A, Yaroslavtseva T, Sinha R, Kosten TR. Naltrexone with or without guanfacine for preventing relapse to opiate addiction in St.-Petersburg, Russia. Drug and Alcohol Dependence. 132: 674-80. PMID 23683793 DOI: 10.1016/j.drugalcdep.2013.04.021  0.6
2013 Spellicy CJ, Kosten TR, Hamon SC, Harding MJ, Nielsen DA. ANKK1 and DRD2 pharmacogenetics of disulfiram treatment for cocaine abuse. Pharmacogenetics and Genomics. 23: 333-40. PMID 23635803 DOI: 10.1097/FPC.0b013e328361c39d  0.4
2013 Zhang XY, Chen da C, Xiu MH, Tan YL, Yang FD, Zhang LY, Zhang LY, Haile CN, Kosten TR. Clinical symptoms and cognitive impairment associated with male schizophrenia relate to plasma manganese superoxide dismutase activity: a case-control study. Journal of Psychiatric Research. 47: 1049-53. PMID 23611682 DOI: 10.1016/j.jpsychires.2013.03.014  0.6
2013 Zhang XY, Tang W, Xiu MH, Chen da C, Yang FD, Tan YL, Wang ZR, Zhang F, Liu J, Liu L, Chen Y, Wen N, Kosten TR. Interleukin 18 and cognitive impairment in first episode and drug naïve schizophrenia versus healthy controls. Brain, Behavior, and Immunity. 32: 105-11. PMID 23499732 DOI: 10.1016/j.bbi.2013.03.001  0.6
2013 Brimijoin S, Shen X, Orson F, Kosten T. Prospects, promise and problems on the road to effective vaccines and related therapies for substance abuse Expert Review of Vaccines. 12: 323-332. PMID 23496671 DOI: 10.1586/erv.13.1  0.6
2013 Graham DP, Helmer DA, Harding MJ, Kosten TR, Petersen NJ, Nielsen DA. Serotonin transporter genotype and mild traumatic brain injury independently influence resilience and perception of limitations in veterans. Journal of Psychiatric Research. 47: 835-42. PMID 23478049 DOI: 10.1016/j.jpsychires.2013.02.006  0.6
2013 Wu JQ, Kosten TR, Zhang XY. Free radicals, antioxidant defense systems, and schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 46: 200-6. PMID 23470289 DOI: 10.1016/j.pnpbp.2013.02.015  0.6
2013 Kosten TR, Domingo CB, Hamon SC, Nielsen DA. DBH gene as predictor of response in a cocaine vaccine clinical trial. Neuroscience Letters. 541: 29-33. PMID 23458673 DOI: 10.1016/j.neulet.2013.02.037  0.6
2013 Orson FM, Rossen RD, Shen X, Lopez AY, Wu Y, Kosten TR. Spontaneous development of IgM anti-cocaine antibodies in habitual cocaine users: effect on IgG antibody responses to a cocaine cholera toxin B conjugate vaccine. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 22: 169-74. PMID 23414504 DOI: 10.1111/j.1521-0391.2013.00314.x  0.6
2013 Shorter D, Lindsay JA, Kosten TR. The alpha-1 adrenergic antagonist doxazosin for treatment of cocaine dependence: A pilot study. Drug and Alcohol Dependence. 131: 66-70. PMID 23306096 DOI: 10.1016/j.drugalcdep.2012.11.021  0.6
2013 Zhang XY, Chen da C, Xiu MH, Yang FD, Tan YL, He S, Kosten TA, Kosten TR. Thioredoxin, a novel oxidative stress marker and cognitive performance in chronic and medicated schizophrenia versus healthy controls. Schizophrenia Research. 143: 301-6. PMID 23238053 DOI: 10.1016/j.schres.2012.11.017  0.6
2013 Zhang XY, Chen DC, Xiu MH, Haile CN, He SC, Luo X, Zuo L, Rosenheck R, Kosten TA, Kosten TR. Cigarette smoking, psychopathology and cognitive function in first-episode drug-naive patients with schizophrenia: a case-control study. Psychological Medicine. 43: 1651-60. PMID 23149169 DOI: 10.1017/S0033291712002590  0.44
2013 He J, Xie Y, Tao J, Su H, Wu W, Zou S, Zhang J, Zhang J, Zhang H, Yang X, Guo J, Tang W, Zhang F, Liu J, Liu L, ... ... Kosten TR, et al. Gender differences in socio-demographic and clinical characteristics of methamphetamine inpatients in a Chinese population. Drug and Alcohol Dependence. 130: 94-100. PMID 23149112 DOI: 10.1016/j.drugalcdep.2012.10.014  0.6
2013 Cui Y, Versace F, Engelmann JM, Minnix JA, Robinson JD, Lam CY, Karam-Hage M, Brown VL, Wetter DW, Dani JA, Kosten TR, Cinciripini PM. Alpha oscillations in response to affective and cigarette-related stimuli in smokers. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 15: 917-24. PMID 23060019 DOI: 10.1093/ntr/nts209  0.52
2013 Shen XY, Kosten TA, Lopez AY, Kinsey BM, Kosten TR, Orson FM. A vaccine against methamphetamine attenuates its behavioral effects in mice. Drug and Alcohol Dependence. 129: 41-8. PMID 23022610 DOI: 10.1016/j.drugalcdep.2012.09.007  0.6
2013 Brimijoin S, Orson F, Kosten TR, Kinsey B, Shen XY, White SJ, Gao Y. Anti-cocaine antibody and butyrylcholinesterase-derived cocaine hydrolase exert cooperative effects on cocaine pharmacokinetics and cocaine-induced locomotor activity in mice. Chemico-Biological Interactions. 203: 212-6. PMID 22960160 DOI: 10.1016/j.cbi.2012.08.015  0.6
2013 Gao Y, Geng L, Orson F, Kinsey B, Kosten TR, Shen X, Brimijoin S. Effects of anti-cocaine vaccine and viral gene transfer of cocaine hydrolase in mice on cocaine toxicity including motor strength and liver damage. Chemico-Biological Interactions. 203: 208-11. PMID 22935511 DOI: 10.1016/j.cbi.2012.08.006  0.6
2013 Kosten TR, Wu G, Huang W, Harding MJ, Hamon SC, Lappalainen J, Nielsen DA. Pharmacogenetic randomized trial for cocaine abuse: disulfiram and dopamine β-hydroxylase. Biological Psychiatry. 73: 219-24. PMID 22906516 DOI: 10.1016/j.biopsych.2012.07.011  0.6
2013 Brown AE, Tonigan JS, Pavlik VN, Kosten TR, Volk RJ. Spirituality and confidence to resist substance use among celebrate recovery participants. Journal of Religion and Health. 52: 107-13. PMID 21246280 DOI: 10.1007/s10943-011-9456-x  0.6
2013 Ramakrishnan M, Kinsey BM, Kosten TR, Orson FM. Vaccines for Addictive Disorders Interventions For Addiction. 543-551. DOI: 10.1016/B978-0-12-398338-1.00057-9  0.48
2012 Spellicy CJ, Kosten TR, Hamon SC, Harding MJ, Nielsen DA. The MTHFR C677T Variant is Associated with Responsiveness to Disulfiram Treatment for Cocaine Dependency. Frontiers in Psychiatry. 3: 109. PMID 23335901 DOI: 10.3389/fpsyt.2012.00109  0.4
2012 Zhang XY, Chen da C, Xiu MH, Luo X, Zuo L, Haile CN, Kosten TA, Kosten TR. BDNF Val66Met variant and smoking in a Chinese population. Plos One. 7: e53295. PMID 23285275 DOI: 10.1371/journal.pone.0053295  0.6
2012 Haile CN, De La Garza R, Mahoney JJ, Nielsen DA, Kosten TR, Newton TF. The impact of disulfiram treatment on the reinforcing effects of cocaine: a randomized clinical trial. Plos One. 7: e47702. PMID 23144826 DOI: 10.1371/journal.pone.0047702  0.6
2012 Singh RA, Kosten TA, Kinsey BM, Shen X, Lopez AY, Kosten TR, Orson FM. Dose-dependent changes in the locomotor responses to methamphetamine in BALB/c mice: low doses induce hypolocomotion. Pharmacology, Biochemistry, and Behavior. 103: 230-6. PMID 23010423 DOI: 10.1016/j.pbb.2012.08.013  0.6
2012 Zhang XY, Liu L, Liu S, Hong X, Chen da C, Xiu MH, Yang FD, Zhang Z, Zhang X, Kosten TA, Kosten TR. Short-term tropisetron treatment and cognitive and P50 auditory gating deficits in schizophrenia. The American Journal of Psychiatry. 169: 974-81. PMID 22952075 DOI: 10.1176/appi.ajp.2012.11081289  0.6
2012 Nielsen DA, Harding MJ, Hamon SC, Huang W, Kosten TR. Modifying the role of serotonergic 5-HTTLPR and TPH2 variants on disulfiram treatment of cocaine addiction: a preliminary study. Genes, Brain, and Behavior. 11: 1001-8. PMID 22925276 DOI: 10.1111/j.1601-183X.2012.00839.x  0.4
2012 Carroll ME, Zlebnik NE, Anker JJ, Kosten TR, Orson FM, Shen X, Kinsey B, Parks RJ, Gao Y, Brimijoin S. Combined cocaine hydrolase gene transfer and anti-cocaine vaccine synergistically block cocaine-induced locomotion. Plos One. 7: e43536. PMID 22912888 DOI: 10.1371/journal.pone.0043536  0.6
2012 Nielsen DA, Utrankar A, Reyes JA, Simons DD, Kosten TR. Epigenetics of drug abuse: predisposition or response. Pharmacogenomics. 13: 1149-60. PMID 22909205 DOI: 10.2217/pgs.12.94  0.6
2012 Zhang XY, Chen da C, Xiu MH, Yang FD, Haile CN, Kosten TA, Kosten TR. Gender differences in never-medicated first-episode schizophrenia and medicated chronic schizophrenia patients. The Journal of Clinical Psychiatry. 73: 1025-33. PMID 22901352 DOI: 10.4088/JCP.11m07422  0.6
2012 Zhang XY, Chen da C, Xiu MH, Hui L, Liu H, Luo X, Zuo L, Zhang H, Kosten TA, Kosten TR. Association of functional dopamine-beta-hydroxylase (DBH) 19 bp insertion/deletion polymorphism with smoking severity in male schizophrenic smokers. Schizophrenia Research. 141: 48-53. PMID 22871345 DOI: 10.1016/j.schres.2012.07.011  0.6
2012 Ramakrishnan M, Alves De Melo F, Kinsey BM, Ladbury JE, Kosten TR, Orson FM. Probing cocaine-antibody interactions in buffer and human serum. Plos One. 7: e40518. PMID 22859949 DOI: 10.1371/journal.pone.0040518  0.6
2012 Han M, Huang XF, Chen da C, Xiu MH, Hui L, Liu H, Kosten TR, Zhang XY. Gender differences in cognitive function of patients with chronic schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 39: 358-63. PMID 22820676 DOI: 10.1016/j.pnpbp.2012.07.010  0.6
2012 Zhang X, Guan SL, Wang ZQ, You Y, Sun SL, Hui L, Miao LN, Yu Y, Kosten TR, Zhang XY. No association between the type 2 diabetes mellitus susceptibility gene, SLC30A8 and schizophrenia in a Chinese population. Human Psychopharmacology. 27: 392-6. PMID 22778022 DOI: 10.1002/hup.2239  0.6
2012 Sun H, Guo S, Chen D, Yang F, Zou Y, Di X, Cao Y, Kosten T, Lu L, Zhang XY. Association of functional COMT Val108/Met polymorphism with smoking cessation in a nicotine replacement therapy. Journal of Neural Transmission (Vienna, Austria : 1996). 119: 1491-8. PMID 22695756 DOI: 10.1007/s00702-012-0841-8  0.6
2012 Zhang XY, Zhang WF, Zhou DF, Chen da C, Xiu MH, Wu HR, Haile CN, Kosten TA, Kosten TR. Brain-derived neurotrophic factor levels and its Val66Met gene polymorphism predict tardive dyskinesia treatment response to Ginkgo biloba. Biological Psychiatry. 72: 700-6. PMID 22695185 DOI: 10.1016/j.biopsych.2012.04.032  0.6
2012 Xiu MH, Chen da C, Wang D, Zhang K, Dong A, Tang W, Zhang F, Liu LJ, Liu JH, Liu HB, Yang FD, Kosten TR, Zhang XY. Elevated interleukin-18 serum levels in chronic schizophrenia: Association with psychopathology. Journal of Psychiatric Research. 46: 1093-8. PMID 22647522 DOI: 10.1016/j.jpsychires.2012.04.026  0.6
2012 Cui Y, Robinson JD, Versace F, Lam CY, Minnix JA, Karam-Hage M, Dani JA, Kosten TR, Wetter DW, Brown VL, Cinciripini PM. Differential cigarette-related startle cue reactivity among light, moderate, and heavy smokers. Addictive Behaviors. 37: 885-9. PMID 22571920 DOI: 10.1016/j.addbeh.2012.02.003  0.52
2012 Zhang XY, Chen da C, Xiu MH, Haile CN, Sun H, Lu L, Kosten TA, Kosten TR. Cigarette smoking and cognitive function in Chinese male schizophrenia: a case-control study. Plos One. 7: e36563. PMID 22570726 DOI: 10.1371/journal.pone.0036563  0.44
2012 Zhang XY, Chen da C, Xiu MH, Tang W, Zhang F, Liu L, Chen Y, Liu J, Yao JK, Kosten TA, Kosten TR. Plasma total antioxidant status and cognitive impairments in schizophrenia. Schizophrenia Research. 139: 66-72. PMID 22555016 DOI: 10.1016/j.schres.2012.04.009  0.6
2012 Hui L, Zhang X, Huang XF, Han M, Fernandez F, Yu Y, Sun S, Li W, Chen da C, Xiu MH, Kosten TR, Zhang XY. The dopamine b-hydroxylase 19 bp insertion/deletion polymorphism was associated with first-episode but not medicated chronic schizophrenia. Journal of Psychiatric Research. 46: 733-7. PMID 22445279 DOI: 10.1016/j.jpsychires.2012.02.016  0.6
2012 Liu H, Kang Y, Liang J, Li C, Xiu M, Chen D, Yang F, Wang F, Wu G, Haile CN, Kosten TA, Kosten TR, Zhang XY. Lower serum interleukin-2 levels in schizophrenic patients with tardive dyskinesia. Psychiatry Research. 198: 329-31. PMID 22417931 DOI: 10.1016/j.psychres.2012.01.002  0.6
2012 Zhang XY, Chen da C, Xiu MH, Haile CN, Luo X, Xu K, Zhang HP, Zuo L, Zhang Z, Zhang X, Kosten TA, Kosten TR. Cognitive and serum BDNF correlates of BDNF Val66Met gene polymorphism in patients with schizophrenia and normal controls. Human Genetics. 131: 1187-95. PMID 22362486 DOI: 10.1007/s00439-012-1150-x  0.6
2012 Zhang XY, Liang J, Chen da C, Xiu MH, He J, Cheng W, Wu Z, Yang FD, Haile CN, Sun H, Lu L, Kosten TA, Kosten TR. Cigarette smoking in male patients with chronic schizophrenia in a Chinese population: prevalence and relationship to clinical phenotypes. Plos One. 7: e30937. PMID 22347412 DOI: 10.1371/journal.pone.0030937  0.6
2012 Newton TF, De La Garza R, Brown G, Kosten TR, Mahoney JJ, Haile CN. Noradrenergic α₁ receptor antagonist treatment attenuates positive subjective effects of cocaine in humans: a randomized trial. Plos One. 7: e30854. PMID 22319592 DOI: 10.1371/journal.pone.0030854  0.6
2012 Zhang XY, Liang J, Chen da C, Xiu MH, Yang FD, Kosten TA, Kosten TR. Low BDNF is associated with cognitive impairment in chronic patients with schizophrenia. Psychopharmacology. 222: 277-84. PMID 22274000 DOI: 10.1007/s00213-012-2643-y  0.6
2012 Zhang XY, Zhou DF, Shen YC, Zhang PY, Zhang WF, Liang J, Chen da C, Xiu MH, Kosten TA, Kosten TR. Effects of risperidone and haloperidol on superoxide dismutase and nitric oxide in schizophrenia. Neuropharmacology. 62: 1928-34. PMID 22227558 DOI: 10.1016/j.neuropharm.2011.12.014  0.6
2012 Shen XY, Orson FM, Kosten TR. Vaccines against drug abuse. Clinical Pharmacology and Therapeutics. 91: 60-70. PMID 22130115 DOI: 10.1038/clpt.2011.281  0.48
2012 Kosten TR. Appreciation American Journal On Addictions. DOI: 10.1111/j.1521-0391.2012.00278.x  0.6
2011 Shorter D, Kosten TR. Vaccines in the Treatment of Substance Abuse. Focus (American Psychiatric Publishing). 2011: 25-30. PMID 23472050  0.68
2011 Shorter D, Kosten TR. Novel pharmacotherapeutic treatments for cocaine addiction. Bmc Medicine. 9: 119. PMID 22047090 DOI: 10.1186/1741-7015-9-119  0.6
2011 Wisner KL, Conley RR, Taylor SF, Kosten T, Rapaport MH, Brown LS. Researcher experiences with IRBs: a survey of members of the American College of Neuropsychopharmacology. Irb. 33: 14-20. PMID 22043746  0.6
2011 Shen X, Orson FM, Kosten TR. Anti-addiction vaccines. F1000 Medicine Reports. 3: 20. PMID 22003367 DOI: 10.3410/M3-20  0.6
2011 Zhang R, Hao W, Pan M, Wang C, Zhang X, Chen da C, Xiu MH, Yang FD, Kosten TR, Zhang XY. The prevalence and clinical-demographic correlates of diabetes mellitus in chronic schizophrenic patients receiving clozapine. Human Psychopharmacology. 26: 392-6. PMID 21826737 DOI: 10.1002/hup.1220  0.6
2011 Yang YQ, Sun S, Yu YQ, Li WJ, Zhang X, Xiu MH, Chen da C, De Yang F, Liu H, Li C, Kosten TR, Zhang XY. Decreased serum brain-derived neurotrophic factor levels in schizophrenic patients with tardive dyskinesia. Neuroscience Letters. 502: 37-40. PMID 21798311 DOI: 10.1016/j.neulet.2011.07.020  0.6
2011 Zhang XY, Yu YQ, Sun S, Zhang X, Li W, Xiu MH, Chen da C, Yang FD, Zhu F, Kosten TA, Kosten TR. Smoking and tardive dyskinesia in male patients with chronic schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 35: 1765-9. PMID 21723906 DOI: 10.1016/j.pnpbp.2011.06.006  0.6
2011 Sorensen JL, Kosten T. Developing the tools of implementation science in substance use disorders treatment: applications of the consolidated framework for implementation research. Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors. 25: 262-8. PMID 21668086 DOI: 10.1037/a0022765  0.6
2011 Kosten TR. Stress and addiction. The American Journal of Psychiatry. 168: 566-8. PMID 21642477 DOI: 10.1176/appi.ajp.2011.11020180  0.6
2011 Dodrill CL, Helmer DA, Kosten TR. Prescription pain medication dependence. The American Journal of Psychiatry. 168: 466-71. PMID 21536702 DOI: 10.1176/appi.ajp.2010.10020260  0.6
2011 Li XF, Zheng YL, Xiu MH, Chen da C, Kosten TR, Zhang XY. Reduced plasma total antioxidant status in first-episode drug-naive patients with schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 35: 1064-7. PMID 21392552 DOI: 10.1016/j.pnpbp.2011.03.001  0.6
2011 Yang FD, Wang XQ, Liu XP, Zhao KX, Fu WH, Hao XR, Zhang XL, Huang GS, Qu SC, Bai JS, Huang XF, Kosten TR, Zhang XY. Sex difference in QTc prolongation in chronic institutionalized patients with schizophrenia on long-term treatment with typical and atypical antipsychotics. Psychopharmacology. 216: 9-16. PMID 21301815 DOI: 10.1007/s00213-011-2188-5  0.6
2011 McIntosh BJ, Zhang XY, Kosten T, Tan SP, Xiu MH, Rakofsky J, Harvey PD. Performance-based assessment of functional skills in severe mental illness: Results of a large-scale study in China Journal of Psychiatric Research. 45: 1089-1094. PMID 21300378 DOI: 10.1016/j.jpsychires.2011.01.012  0.6
2011 Cao JX, Hu J, Ye XM, Xia Y, Haile CA, Kosten TR, Zhang XY. Association between the 5-HTR1B gene polymorphisms and alcohol dependence in a Han Chinese population. Brain Research. 1376: 1-9. PMID 21172311 DOI: 10.1016/j.brainres.2010.12.039  0.6
2011 Sofuoglu M, Mooney M, Kosten T, Waters A, Hashimoto K. Minocycline attenuates subjective rewarding effects of dextroamphetamine in humans Psychopharmacology. 213: 61-68. PMID 20838775 DOI: 10.1007/s00213-010-2014-5  0.6
2011 Oliveto A, Poling J, Mancino MJ, Feldman Z, Cubells JF, Pruzinsky R, Gonsai K, Cargile C, Sofuoglu M, Chopra MP, Gonzalez-Haddad G, Carroll KM, Kosten TR. Randomized, double blind, placebo-controlled trial of disulfiram for the treatment of cocaine dependence in methadone-stabilized patients. Drug and Alcohol Dependence. 113: 184-91. PMID 20828943 DOI: 10.1016/j.drugalcdep.2010.07.022  0.6
2011 Chen da C, Zhou MA, Zhou DH, Xiu MH, Wu GY, Kosten TR, Zhang XY. Gender differences in the prevalence of diabetes mellitus in chronic hospitalized patients with schizophrenia on long-term antipsychotics. Psychiatry Research. 186: 451-3. PMID 20797801 DOI: 10.1016/j.psychres.2010.07.054  0.6
2011 Najavits LM, Kivlahan D, Kosten T. A national survey of clinicians' views of evidence-based therapies for PTSD and substance abuse Addiction Research and Theory. 19: 138-147. DOI: 10.3109/16066350903560176  0.6
2011 Dodrill CL, Helmer DA, Kosten TR. Response to Lustman et al. letter American Journal of Psychiatry. 168: 1118-1119. DOI: 10.1176/appi.ajp.2011.11060869r  0.6
2011 Shorter D, Kosten TR. Antidrug vaccines fact or science fiction? Psychiatric Times. 28: 28-37.  0.6
2011 Kosten T. Shooting down addiction a new breed of vaccines aims to wean users off cocaine Scientist. 25.  0.6
2010 Kinsey BM, Kosten TR, Orson FM. Active immunotherapy for the Treatment of Cocaine Dependence. Drugs of the Future. 35: 301-306. PMID 21796226 DOI: 10.1358/dof.2010.035.04.1474292  0.6
2010 Cosgrove KP, Tellez-Jacques K, Pittman B, Petrakis I, Baldwin RM, Tamagnan G, Seibyl J, Kosten T, Staley JK. Dopamine and serotonin transporter availability in chronic heroin users: a [¹²³I]β-CIT SPECT imaging study. Psychiatry Research. 184: 192-5. PMID 21050726 DOI: 10.1016/j.pscychresns.2010.08.001  0.6
2010 Kinsey BM, Kosten TR, Orson FM. Anti-cocaine vaccine development. Expert Review of Vaccines. 9: 1109-14. PMID 20822352 DOI: 10.1586/erv.10.102  0.6
2010 Li SX, Liu LJ, Jiang WG, Sun LL, Zhou SJ, Le Foll B, Zhang XY, Kosten TR, Lu L. Circadian alteration in neurobiology during protracted opiate withdrawal in rats. Journal of Neurochemistry. 115: 353-62. PMID 20738730 DOI: 10.1111/j.1471-4159.2010.06941.x  0.6
2010 Zhang XY, Xiu MH, Chen da C, Yang FD, Wu GY, Lu L, Kosten TA, Kosten TR. Nicotine dependence and serum BDNF levels in male patients with schizophrenia. Psychopharmacology. 212: 301-7. PMID 20661552 DOI: 10.1007/s00213-010-1956-y  0.6
2010 Oliveto A, Gentry WB, Pruzinsky R, Gonsai K, Kosten TR, Martell B, Poling J. Behavioral effects of gamma-hydroxybutyrate in humans. Behavioural Pharmacology. 21: 332-42. PMID 20526195 DOI: 10.1097/FBP.0b013e32833b3397  0.6
2010 Najavits LM, Norman SB, Kivlahan D, Kosten TR. Improving PTSD/substance abuse treatment in the VA: a survey of providers. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 19: 257-63. PMID 20525033 DOI: 10.1111/j.1521-0391.2010.00039.x  0.6
2010 Zhang XY, Xiu MH, Song C, Chen da C, Wu GY, Haile CN, Kosten TA, Kosten TR. Increased serum S100B in never-medicated and medicated schizophrenic patients. Journal of Psychiatric Research. 44: 1236-40. PMID 20510426 DOI: 10.1016/j.jpsychires.2010.04.023  0.6
2010 Zhou DH, Yan QZ, Yan XM, Li CB, Fang H, Zheng YL, Zhang CX, Yao HJ, Chen da C, Xiu MH, Kosten TR, Zhang XY. The study of BDNF Val66Met polymorphism in Chinese schizophrenic patients. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 34: 930-3. PMID 20420877 DOI: 10.1016/j.pnpbp.2010.04.019  0.6
2010 Chen da C, Xiu MH, Liu H, Zhang BS, Wang Y, Kosten TR, Zhang XY. Reduced status of plasma total antioxidant capacity in schizophrenia with tardive dyskinesia. Journal of Psychiatric Research. 44: 1111-2. PMID 20398909 DOI: 10.1016/j.jpsychires.2010.03.008  0.6
2010 Wang Y, Wang JD, Wu HR, Zhang BS, Fang H, Ma QM, Liu H, Chen da C, Xiu MH, Hail CN, Kosten TR, Zhang XY. The Val66Met polymorphism of the brain-derived neurotrophic factor gene is not associated with risk for schizophrenia and tardive dyskinesia in Han Chinese population. Schizophrenia Research. 120: 240-2. PMID 20395113 DOI: 10.1016/j.schres.2010.03.020  0.6
2010 Liu H, Wang C, Chen PH, Zhang BS, Zheng YL, Zhang CX, Meng HQ, Wang Y, Chen da C, Xiu MH, Kosten TR, Zhang XY. Association of the manganese superoxide dismutase gene Ala-9Val polymorphism with clinical phenotypes and tardive dyskinesia in schizophrenic patients. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 34: 692-6. PMID 20346996 DOI: 10.1016/j.pnpbp.2010.03.026  0.6
2010 Zhang XY, Zhang RL, Pan M, Chen da C, Xiu MH, Kosten TR. Sex difference in the prevalence of smoking in Chinese schizophrenia. Journal of Psychiatric Research. 44: 986-8. PMID 20334878 DOI: 10.1016/j.jpsychires.2010.02.015  0.6
2010 Gao Y, Orson FM, Kinsey B, Kosten T, Brimijoin S. The concept of pharmacologic cocaine interception as a treatment for drug abuse Chemico-Biological Interactions. 187: 421-424. PMID 20219449 DOI: 10.1016/j.cbi.2010.02.036  0.6
2010 Zhang XY, Li CB, Li M, Zheng YL, Zhang CX, Yan QZ, Liu WZ, Kang YM, Wang F, Chen da C, Xiu MH, Kosten TR. Smoking initiation and schizophrenia: a replication study in a Chinese Han population. Schizophrenia Research. 119: 110-4. PMID 20022218 DOI: 10.1016/j.schres.2009.11.012  0.6
2010 Zhang XY, Xiu MH, Chen da C, Zhu FY, Wu GY, Haile CN, Lu L, Kosten TA, Kosten TR. Increased S100B serum levels in schizophrenic patients with tardive dyskinesia: association with dyskinetic movements. Journal of Psychiatric Research. 44: 429-33. PMID 19932492 DOI: 10.1016/j.jpsychires.2009.10.012  0.6
2010 Zhao LY, Shi J, Zhang XL, Epstein DH, Zhang XY, Liu Y, Kosten TR, Lu L. Stress enhances retrieval of drug-related memories in abstinent heroin addicts. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 720-6. PMID 19890257 DOI: 10.1038/npp.2009.179  0.6
2010 Stitzer ML, Polk T, Bowles S, Kosten T. Drug users' adherence to a 6-month vaccination protocol: effects of motivational incentives. Drug and Alcohol Dependence. 107: 76-9. PMID 19828264 DOI: 10.1016/j.drugalcdep.2009.09.006  0.6
2009 Castells X, Kosten TR, Capellà D, Vidal X, Colom J, Casas M. Efficacy of opiate maintenance therapy and adjunctive interventions for opioid dependence with comorbid cocaine use disorders: A systematic review and meta-analysis of controlled clinical trials. The American Journal of Drug and Alcohol Abuse. 35: 339-49. PMID 20180662 DOI: 10.1080/00952990903108215  0.6
2009 Sofuoglu M, Poling J, Hill K, Kosten T. Atomoxetine attenuates dextroamphetamine effects in humans American Journal of Drug and Alcohol Abuse. 35: 412-416. PMID 20014909 DOI: 10.3109/00952990903383961  0.6
2009 Lu L, Wang X, Kosten TR. Stereotactic neurosurgical treatment of drug addiction. The American Journal of Drug and Alcohol Abuse. 35: 391-3. PMID 20014906 DOI: 10.3109/00952990903312478  0.6
2009 Haile CN, Kosten TR. The potential of pharmacogenomics to treat drug addiction. Pharmacogenomics. 10: 1883-6. PMID 19958085 DOI: 10.2217/pgs.09.146  0.6
2009 Martell BA, Orson FM, Poling J, Mitchell E, Rossen RD, Gardner T, Kosten TR. Cocaine vaccine for the treatment of cocaine dependence in methadone-maintained patients: a randomized, double-blind, placebo-controlled efficacy trial. Archives of General Psychiatry. 66: 1116-23. PMID 19805702 DOI: 10.1001/archgenpsychiatry.2009.128  0.6
2009 Chen da C, Wang J, Wang B, Yang SC, Zhang CX, Zheng YL, Li YL, Wang N, Yang KB, Xiu MH, Kosten TR, Zhang XY. Decreased levels of serum brain-derived neurotrophic factor in drug-naïve first-episode schizophrenia: relationship to clinical phenotypes. Psychopharmacology. 207: 375-80. PMID 19787338 DOI: 10.1007/s00213-009-1665-6  0.6
2009 Xiu MH, Hui L, Dang YF, Hou TD, Zhang CX, Zheng YL, Chen da C, Kosten TR, Zhang XY. Decreased serum BDNF levels in chronic institutionalized schizophrenia on long-term treatment with typical and atypical antipsychotics. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 33: 1508-12. PMID 19720106 DOI: 10.1016/j.pnpbp.2009.08.011  0.6
2009 Chen JX, Su YA, Wang SL, Bian QT, Liu YH, Wang N, Yang FD, Haile C, Kosten TR, Zhang XY. Aripiprazole treatment of risperidone-induced hyperprolactinemia. The Journal of Clinical Psychiatry. 70: 1058-9. PMID 19653986 DOI: 10.4088/JCP.08l04671  0.6
2009 Shi J, Li SX, Zhang XL, Wang X, Le Foll B, Zhang XY, Kosten TR, Lu L. Time-dependent neuroendocrine alterations and drug craving during the first month of abstinence in heroin addicts. The American Journal of Drug and Alcohol Abuse. 35: 267-72. PMID 19591065 DOI: 10.1080/00952990902933878  0.6
2009 Qiu HT, Meng HQ, Song C, Xiu MH, Chen da C, Zhu FY, Wu GY, Kosten TA, Kosten TR, Zhang XY. Association between monoamine oxidase (MAO)-A gene variants and schizophrenia in a Chinese population. Brain Research. 1287: 67-73. PMID 19573521 DOI: 10.1016/j.brainres.2009.06.072  0.6
2009 Zhang XY, Chen da C, Xiu MH, Wang F, Qi LY, Sun HQ, Chen S, He SC, Wu GY, Haile CN, Kosten TA, Lu L, Kosten TR. The novel oxidative stress marker thioredoxin is increased in first-episode schizophrenic patients. Schizophrenia Research. 113: 151-7. PMID 19540723 DOI: 10.1016/j.schres.2009.05.016  0.6
2009 Qi LY, Xiu MH, Chen da C, Wang F, Kosten TA, Kosten TR, Zhang XY. Increased serum S100B levels in chronic schizophrenic patients on long-term clozapine or typical antipsychotics. Neuroscience Letters. 462: 113-7. PMID 19539717 DOI: 10.1016/j.neulet.2009.06.019  0.6
2009 Stotts AL, Dodrill CL, Kosten TR. Opioid dependence treatment: options in pharmacotherapy. Expert Opinion On Pharmacotherapy. 10: 1727-40. PMID 19538000 DOI: 10.1517/14656560903037168  0.6
2009 Zhang XY, Chen da C, Qi LY, Wang F, Xiu MH, Chen S, Wu GY, Kosten TA, Kosten TR. Gender differences in the prevalence, risk and clinical correlates of tardive dyskinesia in Chinese schizophrenia. Psychopharmacology. 205: 647-54. PMID 19529921 DOI: 10.1007/s00213-009-1590-8  0.6
2009 Shi J, Jun W, Zhao LY, Xue YX, Zhang XY, Kosten TR, Lu L. Effect of rapamycin on cue-induced drug craving in abstinent heroin addicts. European Journal of Pharmacology. 615: 108-12. PMID 19470385 DOI: 10.1016/j.ejphar.2009.05.011  0.6
2009 Sun HQ, Guo S, Chen DF, Jiang ZN, Liu Y, Di XL, Yang FD, Zhang XY, Kosten TR, Lu L. Family support and employment as predictors of smoking cessation success: a randomized, double-blind, placebo-controlled trial of nicotine sublingual tablets in chinese smokers. The American Journal of Drug and Alcohol Abuse. 35: 183-8. PMID 19462302 DOI: 10.1080/00952990902839794  0.6
2009 Haile CN, Kosten TR, Kosten TA. Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine. The American Journal of Drug and Alcohol Abuse. 35: 161-77. PMID 19462300 DOI: 10.1080/00952990902825447  0.6
2009 Orson FM, Kinsey BM, Singh RA, Wu Y, Kosten TR. Vaccines for cocaine abuse. Human Vaccines. 5: 194-9. PMID 19276665 DOI: 10.4161/hv.5.4.7457  0.6
2009 Lu L, Liu Y, Zhu W, Shi J, Liu Y, Ling W, Kosten TR. Traditional medicine in the treatment of drug addiction. The American Journal of Drug and Alcohol Abuse. 35: 1-11. PMID 19152199 DOI: 10.1080/00952990802455469  0.6
2009 Zhang XY, Zhou DF, Qi LY, Chen S, Cao LY, Chen da C, Xiu MH, Wang F, Wu GY, Lu L, Kosten TA, Kosten TR. Superoxide dismutase and cytokines in chronic patients with schizophrenia: association with psychopathology and response to antipsychotics. Psychopharmacology. 204: 177-84. PMID 19139851 DOI: 10.1007/s00213-008-1447-6  0.6
2009 Li SX, Shi J, Epstein DH, Wang X, Zhang XL, Bao YP, Zhang D, Zhang XY, Kosten TR, Lu L. Circadian alteration in neurobiology during 30 days of abstinence in heroin users. Biological Psychiatry. 65: 905-12. PMID 19135652 DOI: 10.1016/j.biopsych.2008.11.025  0.6
2009 Ren ZY, Zhang XL, Liu Y, Zhao LY, Shi J, Bao Y, Zhang XY, Kosten TR, Lu L. Diurnal variation in cue-induced responses among protracted abstinent heroin users. Pharmacology, Biochemistry, and Behavior. 91: 468-72. PMID 18809427 DOI: 10.1016/j.pbb.2008.08.023  0.6
2008 Orson FM, Kinsey BM, Singh RA, Wu Y, Gardner T, Kosten TR. Substance abuse vaccines. Annals of the New York Academy of Sciences. 1141: 257-69. PMID 18991962 DOI: 10.1196/annals.1441.027  0.6
2008 Xiu MH, Chen S, Wang F, Cao LY, Qi LY, Chen da C, Wu GY, Lu L, Kosten TA, Kosten TR, Zhang XY. Altered interleukin-3 serum levels in drug-naïve and neuroleptic-treated schizophrenic patients. Schizophrenia Research. 106: 369-70. PMID 18838250 DOI: 10.1016/j.schres.2008.09.001  0.6
2008 Chen da C, Qi LY, Xiu MH, Cao LY, Wang F, Chen S, Wu GY, Kosten TA, Kosten TR, Zhang XY. Elevated serum levels of tumor necrosis factor-alpha in clozapine-associated obesity in chronic schizophrenia. Schizophrenia Research. 106: 367-8. PMID 18835132 DOI: 10.1016/j.schres.2008.08.030  0.6
2008 Zhang XY, Cao LY, Song C, Wu GY, Chen da C, Qi LY, Wang F, Xiu MH, Chen S, Zhang Y, Lu L, Kosten TA, Kosten TR. Lower serum cytokine levels in smokers than nonsmokers with chronic schizophrenia on long-term treatment with antipsychotics. Psychopharmacology. 201: 383-9. PMID 18719893 DOI: 10.1007/s00213-008-1295-4  0.6
2008 Haile CN, Kosten TA, Kosten TR. Pharmacogenetic treatments for drug addiction: alcohol and opiates. The American Journal of Drug and Alcohol Abuse. 34: 355-81. PMID 18584566 DOI: 10.1080/00952990802122564  0.6
2008 Sun S, Wang F, Wei J, Cao LY, Wu GY, Lu L, Kosten TA, Kosten TR, Zhang XY. Association between interleukin-3 receptor alpha polymorphism and schizophrenia in the Chinese population. Neuroscience Letters. 440: 35-7. PMID 18547720 DOI: 10.1016/j.neulet.2008.05.029  0.6
2008 Sun S, Wang F, Wei J, Cao LY, Qi LY, Xiu MH, Chen S, Li XH, Kosten TA, Kosten TR, Zhang XY. Association between interleukin-6 receptor polymorphism and patients with schizophrenia. Schizophrenia Research. 102: 346-7. PMID 18508242 DOI: 10.1016/j.schres.2008.04.018  0.6
2008 Li SX, Li J, Epstein DH, Zhang XY, Kosten TR, Lu L. Serum cortisol secretion during heroin abstinence is elevated only nocturnally. The American Journal of Drug and Alcohol Abuse. 34: 321-8. PMID 18428074 DOI: 10.1080/00952990802013664  0.6
2008 Wang F, Xiu MH, Zhou DF, Cao LY, Wu GY, Kosten TA, Kosten TR, Zhang XY. The CCR5 32-bp deletion allele is rare in a Chinese population. Schizophrenia Research. 101: 341-3. PMID 18295459 DOI: 10.1016/j.schres.2008.01.015  0.6
2008 Kosten TR, Gardner TJ. New hot topics sections: 1. China's new march forward in addiction treatment: methadone for the masses. 2. Issues in formulating DSM V. The American Journal of Drug and Alcohol Abuse. 34: 123-6. PMID 18293228 DOI: 10.1080/00952990701876948  0.6
2008 Zhang XY, Zhou DF, Wu GY, Cao LY, Tan YL, Haile CN, Li J, Lu L, Kosten TA, Kosten TR. BDNF levels and genotype are associated with antipsychotic-induced weight gain in patients with chronic schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 33: 2200-5. PMID 17987059 DOI: 10.1038/sj.npp.1301619  0.6
2008 Gardner TJ, Kosten TR. International implications of HIV and substance abuse American Journal of Drug and Alcohol Abuse. 34: 1-3. DOI: 10.1080/00952990701848251  0.6
2008 Gardner TJ, Kosten TA, Kosten TR. Issues in designing and conducting clinical trials for reward disorders: A clinical view Animal and Translational Models For Cns Drug Discovery. 3: 41-57. DOI: 10.1016/B978-0-12-373861-5.00023-0  0.6
2007 Gardner TJ, Kosten TR. Therapeutic options and challenges for substances of abuse. Dialogues in Clinical Neuroscience. 9: 431-45. PMID 18286802  0.6
2007 Gardner TJ, Kosten TR. Human laboratory and neuroimaging studies in substance use disorders: developing new treatment approaches. The American Journal of Drug and Alcohol Abuse. 33: 765-7. PMID 17994472 DOI: 10.1080/00952990701651549  0.6
2007 Orson FM, Kinsey BM, Singh RA, Wu Y, Gardner T, Kosten TR. The future of vaccines in the management of addictive disorders. Current Psychiatry Reports. 9: 381-7. PMID 17915077 DOI: 10.1007/s11920-007-0049-z  0.6
2007 Lane SD, Moeller FG, Steinberg JL, Buzby M, Kosten TR. Performance of cocaine dependent individuals and controls on a response inhibition task with varying levels of difficulty. The American Journal of Drug and Alcohol Abuse. 33: 717-26. PMID 17891664 DOI: 10.1080/00952990701522724  0.6
2007 Gardner TJ, Kosten TR. Pharmacotherapeutic environments for substance use disorders. The American Journal of Drug and Alcohol Abuse. 33: 627-9. PMID 17891655 DOI: 10.1080/00952990701578676  0.6
2007 Wang ZR, Zhou DF, Cao LY, Tan YL, Zhang XY, Li J, Lu L, Wu GY, Kosten TA, Kosten TR. Brain-derived neurotrophic factor polymorphisms and smoking in schizophrenia. Schizophrenia Research. 97: 299-301. PMID 17869486 DOI: 10.1016/j.schres.2007.08.012  0.6
2007 Li W, Wei J, Zhou DF, Tan YL, Cao YL, Zhang XY, Wu G, Kosten TA, Kosten TR. Lack of association between the BDNF C270T polymorphism and schizophrenia in a Chinese Han population. Schizophrenia Research. 97: 297-8. PMID 17669628 DOI: 10.1016/j.schres.2007.07.005  0.6
2007 Brown AE, Pavlik VN, Shegog R, Whitney SN, Friedman LC, Romero C, Davis GC, Cech I, Kosten TR, Volk RJ. Association of spirituality and sobriety during a behavioral spirituality intervention for Twelve Step (TS) recovery. The American Journal of Drug and Alcohol Abuse. 33: 611-7. PMID 17668347 DOI: 10.1080/00952990701407686  0.6
2007 Kosten TR. Pharmacotherapy for addictions: partnering with contingency management. The American Journal of Drug and Alcohol Abuse. 33: 341-2. PMID 17613962 DOI: 10.1080/00952990701312415  0.6
2007 Poling J, Pruzinsky R, Kosten TR, Gonsai K, Sofuoglu M, Gonzalez G, Oliveto A. Clinical efficacy of citalopram alone or augmented with bupropion in methadone-stabilized patients. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 16: 187-94. PMID 17612822 DOI: 10.1080/10550490701375640  0.6
2007 Kleber HD, Weiss RD, Anton RF, George TP, Greenfield SF, Kosten TR, O'Brien CP, Rounsaville BJ, Strain EC, Ziedonis DM, Hennessy G, Connery HS, McIntyre JS, Charles SC, Anzia DJ, et al. Treatment of patients with substance use disorders, second edition. American Psychiatric Association. The American Journal of Psychiatry. 164: 5-123. PMID 17569411  0.6
2007 Zhang XY, Tan YL, Zhou DF, Cao LY, Wu GY, Haile CN, Kosten TA, Kosten TR. Disrupted antioxidant enzyme activity and elevated lipid peroxidation products in schizophrenic patients with tardive dyskinesia. The Journal of Clinical Psychiatry. 68: 754-60. PMID 17503985  0.6
2007 Zhang XY, Tan YL, Zhou DF, Haile CN, Cao LY, Xu Q, Shen Y, Kosten TA, Kosten TR. Association of clozapine-induced weight gain with a polymorphism in the leptin promoter region in patients with chronic schizophrenia in a Chinese population. Journal of Clinical Psychopharmacology. 27: 246-51. PMID 17502770 DOI: 10.1097/jcp.0b013e3180582412  0.6
2007 Poling J, Kosten TR, Sofuoglu M. Treatment outcome predictors for cocaine dependence. The American Journal of Drug and Alcohol Abuse. 33: 191-206. PMID 17497542 DOI: 10.1080/00952990701199416  0.6
2007 Zhang XY, Tan YL, Zhou DF, Haile CN, Wu GY, Cao LY, Kosten TA, Kosten TR. Nicotine dependence, symptoms and oxidative stress in male patients with schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 32: 2020-4. PMID 17228336 DOI: 10.1038/sj.npp.1301317  0.6
2007 Martell BA, O'Connor PG, Kerns RD, Becker WC, Morales KH, Kosten TR, Fiellin DA. Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction. Annals of Internal Medicine. 146: 116-27. PMID 17227935  0.6
2007 Guo S, Chen da F, Zhou DF, Sun HQ, Wu GY, Haile CN, Kosten TA, Kosten TR, Zhang XY. Association of functional catechol O-methyl transferase (COMT) Val108Met polymorphism with smoking severity and age of smoking initiation in Chinese male smokers. Psychopharmacology. 190: 449-56. PMID 17206495 DOI: 10.1007/s00213-006-0628-4  0.6
2007 Sinha R, Kimmerling A, Doebrick C, Kosten TR. Effects of lofexidine on stress-induced and cue-induced opioid craving and opioid abstinence rates: preliminary findings. Psychopharmacology. 190: 569-74. PMID 17136399 DOI: 10.1007/s00213-006-0640-8  0.6
2007 Zhang XY, Tan YL, Zhou DF, Cao LY, Wu GY, Xu Q, Shen Y, Haile CN, Kosten TA, Kosten TR. Serum BDNF levels and weight gain in schizophrenic patients on long-term treatment with antipsychotics. Journal of Psychiatric Research. 41: 997-1004. PMID 17095017 DOI: 10.1016/j.jpsychires.2006.08.007  0.6
2007 Haile CN, Kosten TR, Kosten TA. Genetics of dopamine and its contribution to cocaine addiction. Behavior Genetics. 37: 119-45. PMID 17063402 DOI: 10.1007/s10519-006-9115-2  0.6
2007 González G, Desai R, Sofuoglu M, Poling J, Oliveto A, Gonsai K, Kosten TR. Clinical efficacy of gabapentin versus tiagabine for reducing cocaine use among cocaine dependent methadone-treated patients. Drug and Alcohol Dependence. 87: 1-9. PMID 16930857 DOI: 10.1016/j.drugalcdep.2006.07.003  0.6
2007 Gardner TJ, Kosten TR. A year in review: Update of progress, changes, and future directions American Journal of Drug and Alcohol Abuse. 33: 503-504. DOI: 10.1080/00952990701407124  0.6
2006 Kleber HD, Weiss RD, Anton RF, Rounsaville BJ, George TP, Strain EC, Greenfield SF, Ziedonis DM, Kosten TR, Hennessy G, O'Brien CP, Connery HS, McIntyre JS, et al. Treatment of patients with substance use disorders, second edition. American Psychiatic Association. The American Journal of Psychiatry. 163: 5-82. PMID 16981488  0.6
2006 Sofuoglu M, Kosten TR. Emerging pharmacological strategies in the fight against cocaine addiction. Expert Opinion On Emerging Drugs. 11: 91-8. PMID 16503828 DOI: 10.1517/14728214.11.1.91  0.6
2006 Li CS, Kosten TR, Sinha R. Antisocial personality and stress-induced brain activation in cocaine-dependent patients. Neuroreport. 17: 243-7. PMID 16462591 DOI: 10.1097/01.wnr.0000199471.06487.a2  0.6
2006 Poling J, Oliveto A, Petry N, Sofuoglu M, Gonsai K, Gonzalez G, Martell B, Kosten TR. Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population. Archives of General Psychiatry. 63: 219-28. PMID 16461866 DOI: 10.1001/archpsyc.63.2.219  0.6
2006 Kosten TR, Scanley BE, Tucker KA, Oliveto A, Prince C, Sinha R, Potenza MN, Skudlarski P, Wexler BE. Cue-induced brain activity changes and relapse in cocaine-dependent patients. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 644-50. PMID 16123763 DOI: 10.1038/sj.npp.1300851  0.6
2006 Kosten TR. Welcome to a new editorial generation American Journal of Drug and Alcohol Abuse. 32: 487-489. DOI: 10.1080/00952990600917082  0.6
2006 Kleber HD, Weiss RD, Anton RF, George TP, Greenfield SF, Kosten TR, O'Brien CP, Rounsaville BJ, Strain EC, Ziedonis DM, Hennessy G, Connery HS, McIntyre JS, Charles SC, Anzia DJ, et al. Treatment of patients with substance use disorders: Second edition American Journal of Psychiatry. 163: 1-81.  0.6
2005 Sofuoglu M, Poling J, Mitchell E, Kosten TR. Tiagabine affects the subjective responses to cocaine in humans. Pharmacology, Biochemistry, and Behavior. 82: 569-73. PMID 16332385 DOI: 10.1016/j.pbb.2005.10.013  0.6
2005 Kosten TR. Future of anti-addiction vaccines. Studies in Health Technology and Informatics. 118: 177-85. PMID 16301778  0.6
2005 Sinha R, Lacadie C, Skudlarski P, Fulbright RK, Rounsaville BJ, Kosten TR, Wexler BE. Neural activity associated with stress-induced cocaine craving: a functional magnetic resonance imaging study. Psychopharmacology. 183: 171-80. PMID 16163517 DOI: 10.1007/s00213-005-0147-8  0.6
2005 Abi-Saab D, Beauvais J, Mehm J, Brody M, Gottschalk C, Kosten TR. The effect of alcohol on the neuropsychological functioning of recently abstinent cocaine-dependent subjects. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 14: 166-78. PMID 16019965 DOI: 10.1080/10550490590924854  0.6
2005 Oliveto A, Poling J, Sevarino KA, Gonsai KR, McCance-Katz EF, Stine SM, Kosten TR. Efficacy of dose and contingency management procedures in LAAM-maintained cocaine-dependent patients. Drug and Alcohol Dependence. 79: 157-65. PMID 16002025 DOI: 10.1016/j.drugalcdep.2005.01.007  0.6
2005 Boutros NN, Lisanby SH, McClain-Furmanski D, Oliwa G, Gooding D, Kosten TR. Cortical excitability in cocaine-dependent patients: a replication and extension of TMS findings. Journal of Psychiatric Research. 39: 295-302. PMID 15725428 DOI: 10.1016/j.jpsychires.2004.07.002  0.6
2005 Kosten TR. Advances in the pharmacotherapy of stimulant dependence: From alcohol antagonists to Xenova vaccines Clinical Neuroscience Research. 5: 169-173. DOI: 10.1016/j.cnr.2005.08.013  0.6
2004 Kosten TR, Kosten TA. New medication strategies for comorbid substance use and bipolar affective disorders. Biological Psychiatry. 56: 771-7. PMID 15556122 DOI: 10.1016/j.biopsych.2004.07.019  0.6
2004 Tucker KA, Potenza MN, Beauvais JE, Browndyke JN, Gottschalk PC, Kosten TR. Perfusion abnormalities and decision making in cocaine dependence. Biological Psychiatry. 56: 527-30. PMID 15450790 DOI: 10.1016/j.biopsych.2004.06.031  0.6
2004 Fiellin DA, Kleber H, Trumble-Hejduk JG, McLellan AT, Kosten TR. Consensus statement on office-based treatment of opioid dependence using buprenorphine. Journal of Substance Abuse Treatment. 27: 153-9. PMID 15450648 DOI: 10.1016/j.jsat.2004.06.005  0.6
2004 Carroll KM, Kosten TR, Rounsaville BJ. Choosing a behavioral therapy platform for pharmacotherapy of substance users. Drug and Alcohol Dependence. 75: 123-34. PMID 15276217 DOI: 10.1016/j.drugalcdep.2004.02.007  0.6
2004 West JC, Kosten TR, Wilk J, Svikis D, Triffleman E, Rae DS, Narrow WE, Duffy FF, Regier DA. Challenges in increasing access to buprenorphine treatment for opiate addiction. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 13: S8-16. PMID 15204672 DOI: 10.1080/10550490490440753  0.6
2004 Oliveto A, Poling J, Kosten TR, Gonsai K. Isradipine and dextromethorphan in methadone-maintained humans under a naloxone discrimination procedure. European Journal of Pharmacology. 491: 157-68. PMID 15140632 DOI: 10.1016/j.ejphar.2004.03.024  0.6
2004 Gonzalez G, Oliveto A, Kosten TR. Combating opiate dependence: a comparison among the available pharmacological options. Expert Opinion On Pharmacotherapy. 5: 713-25. PMID 15102558 DOI: 10.1517/14656566.5.4.713  0.6
2004 Browndyke JN, Tucker KA, Woods SP, Beauvals J, Cohen RA, Gottschalk PC, Kosten TR. Examining the effect of cerebral perfusion abnormality magnitude on cognitive performance in recently abstinent chronic cocaine abusers. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. 14: 162-9. PMID 15095563 DOI: 10.1177/1051228404263276  0.6
2004 Tucker KA, Browndyke JN, Gottschalk PC, Cofrancesco AT, Kosten TR. Gender-specific vulnerability for rCBF abnormalities among cocaine abusers. Neuroreport. 15: 797-801. PMID 15073517 DOI: 10.1097/00001756-200404090-00011  0.6
2004 Haney M, Kosten TR. Therapeutic vaccines for substance dependence. Expert Review of Vaccines. 3: 11-8. PMID 14761239 DOI: 10.1586/14760584.3.1.11  0.6
2003 Gonzalez G, Sevarino K, Sofuoglu M, Poling J, Oliveto A, Gonsai K, George TP, Kosten TR. Tiagabine increases cocaine-free urines in cocaine-dependent methadone-treated patients: results of a randomized pilot study. Addiction (Abingdon, England). 98: 1625-32. PMID 14616189 DOI: 10.1046/j.1360-0443.2003.00544.x  0.6
2003 Haile CN, During MJ, Jatlow PI, Kosten TR, Kosten TA. Disulfiram facilitates the development and expression of locomotor sensitization to cocaine in rats. Biological Psychiatry. 54: 915-21. PMID 14573319 DOI: 10.1016/S0006-3223(03)00241-5  0.6
2003 Gonzalez G, Feingold A, Oliveto A, Gonsai K, Kosten TR. Comorbid major depressive disorder as a prognostic factor in cocaine-abusing buprenorphine-maintained patients treated with desipramine and contingency management. The American Journal of Drug and Alcohol Abuse. 29: 497-514. PMID 14510037 DOI: 10.1081/ADA-120023455  0.6
2003 Sofuoglu M, Singha A, Kosten TR, McCance-Katz FE, Petrakis I, Oliveto A. Effects of naltrexone and isradipine, alone or in combination, on cocaine responses in humans. Pharmacology, Biochemistry, and Behavior. 75: 801-8. PMID 12957222 DOI: 10.1016/S0091-3057(03)00157-6  0.6
2003 Oliveto A, Benios T, Gonsai K, Feingold A, Poling J, Kosten TR. D-cycloserine-Naloxone interactions in opioid-dependent humans under a novel-response naloxone discrimination procedure. Experimental and Clinical Psychopharmacology. 11: 237-46. PMID 12940503 DOI: 10.1037/1064-1297.11.3.237  0.6
2003 George TP, Vessicchio JC, Termine A, Jatlow PI, Kosten TR, O'Malley SS. A preliminary placebo-controlled trial of selegiline hydrochloride for smoking cessation. Biological Psychiatry. 53: 136-43. PMID 12547469 DOI: 10.1016/S0006-3223(02)01454-3  0.6
2002 Kosten TR, George TP. The neurobiology of opioid dependence: implications for treatment. Science & Practice Perspectives / a Publication of the National Institute On Drug Abuse, National Institutes of Health. 1: 13-20. PMID 18567959  0.6
2002 George TP, Vessicchio JC, Termine A, Bregartner TA, Feingold A, Rounsaville BJ, Kosten TR. A placebo controlled trial of bupropion for smoking cessation in schizophrenia. Biological Psychiatry. 52: 53-61. PMID 12079730 DOI: 10.1016/S0006-3223(02)01339-2  0.6
2002 Gonzalez G, Oliveto A, Kosten TR. Treatment of heroin (diamorphine) addiction: current approaches and future prospects. Drugs. 62: 1331-43. PMID 12076182  0.6
2002 Feingold A, Oliveto A, Schottenfeld R, Kosten TR. Utility of crossover designs in clinical trials: efficacy of desipramine vs. placebo in opioid-dependent cocaine abusers. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 11: 111-23. PMID 12028741 DOI: 10.1080/10550490290087884  0.6
2002 Kosten TR, George TP, Kosten TA. The potential of dopamine agonists in drug addiction. Expert Opinion On Investigational Drugs. 11: 491-9. PMID 11922858 DOI: 10.1517/13543784.11.4.491  0.6
2002 Kosten TR, Oliveto A, Sevarino KA, Gonsai K, Feingold A. Ketoconazole increases cocaine and opioid use in methadone maintained patients. Drug and Alcohol Dependence. 66: 173-80. PMID 11906804 DOI: 10.1016/S0376-8716(01)00198-3  0.6
2002 Kosten TR, Gorelick DA. The Lexington narcotic farm. The American Journal of Psychiatry. 159: 22. PMID 11772684  0.6
2002 George TP, Vessicchio JC, Termine A, Sahady DM, Head CA, Pepper WT, Kosten TR, Wexler BE. Effects of smoking abstinence on visuospatial working memory function in schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 26: 75-85. PMID 11751034 DOI: 10.1016/S0893-133X(01)00296-2  0.6
2001 McCance-Katz EF, Kosten TA, Kosten TR. Going from the bedside back to the bench with ecopipam: a new strategy for cocaine pharmacotherapy development. Psychopharmacology. 155: 327-9. PMID 11441421 DOI: 10.1007/s002130100745  0.6
2001 Oliveto A, McCance-Katz FE, Singha A, Petrakis I, Hameedi F, Kosten TR. Effects of cocaine prior to and during bupropion maintenance in cocaine-abusing volunteers. Drug and Alcohol Dependence. 63: 155-67. PMID 11376920 DOI: 10.1016/S0376-8716(00)00198-8  0.6
2001 Stine SM, Grillon CG, Morgan CA, Kosten TR, Charney DS, Krystal JH. Methadone patients exhibit increased startle and cortisol response after intravenous yohimbine. Psychopharmacology. 154: 274-81. PMID 11351934 DOI: 10.1007/s002130000644  0.6
2001 D'Souza DC, Kosten TR. Cannabinoid antagonists: a treatment in search of an illness. Archives of General Psychiatry. 58: 330-1. PMID 11296092  0.6
2001 Jacobsen LK, Giedd JN, Gottschalk C, Kosten TR, Krystal JH. Quantitative morphology of the caudate and putamen in patients with cocaine dependence. The American Journal of Psychiatry. 158: 486-9. PMID 11229995 DOI: 10.1176/appi.ajp.158.3.486  0.6
2001 Jacobsen LK, Giedd JN, Kreek MJ, Gottschalk C, Kosten TR. Quantitative medial temporal lobe brain morphology and hypothalamic-pituitary-adrenal axis function in cocaine dependence: a preliminary report. Drug and Alcohol Dependence. 62: 49-56. PMID 11173167 DOI: 10.1016/S0376-8716(00)00159-9  0.6
2000 Singha AK, McCance-Katz EF, Petrakis I, Kosten TR, Oliveto A. Sex differences in self-reported and physiological response to oral cocaine and placebo in humans. The American Journal of Drug and Alcohol Abuse. 26: 643-57. PMID 11097197 DOI: 10.1081/ADA-100101900  0.6
2000 George TP, Ziedonis DM, Feingold A, Pepper WT, Satterburg CA, Winkel J, Rounsaville BJ, Kosten TR. Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia. The American Journal of Psychiatry. 157: 1835-42. PMID 11058482 DOI: 10.1176/appi.ajp.157.11.1835  0.6
2000 Sevarino KA, Oliveto A, Kosten TR. Neurobiological adaptations to psychostimulants and opiates as a basis of treatment development. Annals of the New York Academy of Sciences. 909: 51-87. PMID 10911924  0.6
2000 George TP, Chawarski MC, Pakes J, Carroll KM, Kosten TR, Schottenfeld RS. Disulfiram versus placebo for cocaine dependence in buprenorphine-maintained subjects: a preliminary trial. Biological Psychiatry. 47: 1080-6. PMID 10862808 DOI: 10.1016/S0006-3223(99)00310-8  0.6
2000 Schottenfeld RS, Pakes J, O'Connor P, Chawarski M, Oliveto A, Kosten TR. Thrice-weekly versus daily buprenorphine maintenance. Biological Psychiatry. 47: 1072-9. PMID 10862807 DOI: 10.1016/S0006-3223(99)00270-X  0.6
2000 Winther LC, Saleem R, McCance-Katz EF, Rosen MI, Hameedi FA, Pearsall HR, Jatlow PI, Kosten TR, Woods SW. Effects of lamotrigine on behavioral and cardiovascular responses to cocaine in human subjects. The American Journal of Drug and Alcohol Abuse. 26: 47-59. PMID 10718163 DOI: 10.1081/ADA-100100590  0.6
1999 Oliveto AH, Feingold A, Schottenfeld R, Jatlow P, Kosten TR. Desipramine in opioid-dependent cocaine abusers maintained on buprenorphine vs methadone. Archives of General Psychiatry. 56: 812-20. PMID 12884887 DOI: 10.1001/archpsyc.56.9.812  0.6
1999 Singha AK, McCance-Katz EF, Heck SA, Kosten TR, Oliveto A. Individual differences in humans responding under a cocaine discrimination procedure: discriminators versus nondiscriminators. Experimental and Clinical Psychopharmacology. 7: 391-8. PMID 10609974 DOI: 10.1037//1064-1297.7.4.391  0.6
1999 Rosen MI, Kosten TR, Kreek MJ. The effects of naltrexone maintenance on the response to yohimbine in healthy volunteers. Biological Psychiatry. 45: 1636-45. PMID 10376126  0.44
1999 Kosten TR, Woods SW, Rosen MI, Pearsall HR. Interactions of cocaine with nimodipine: a brief report. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 8: 77-81. PMID 10189518 DOI: 10.1080/105504999306117  0.6
1999 Avants SK, Margolin A, Sindelar JL, Rounsaville BJ, Schottenfeld R, Stine S, Cooney NL, Rosenheck RA, Li SH, Kosten TR. Day treatment versus enhanced standard methadone services for opioid-dependent patients: a comparison of clinical efficacy and cost. The American Journal of Psychiatry. 156: 27-33. PMID 9892294  0.6
1998 Kosten TR, Markou A, Koob GF. Depression and stimulant dependence: neurobiology and pharmacotherapy. The Journal of Nervous and Mental Disease. 186: 737-45. PMID 9865811 DOI: 10.1097/00005053-199812000-00001  0.6
1998 Oliveto AH, McCance-Katz E, Singha A, Hameedi F, Kosten TR. Effects of d-amphetamine and caffeine in humans under a cocaine discrimination procedure. Behavioural Pharmacology. 9: 207-17. PMID 9832935  0.6
1998 Oliveto AH, Farren C, Kosten TR. Effect of LAAM dose on opiate use in opioid-dependent patients. A pilot study. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 7: 272-82. PMID 9809131  0.6
1998 Rosen MI, Pearsall HR, Kosten TR. The effect of lamotrigine on naloxone-precipitated opiate withdrawal. Drug and Alcohol Dependence. 52: 173-6. PMID 9800147  0.44
1998 O'Connor PG, Oliveto AH, Shi JM, Triffleman EG, Carroll KM, Kosten TR, Rounsaville BJ, Pakes JA, Schottenfeld RS. A randomized trial of buprenorphine maintenance for heroin dependence in a primary care clinic for substance users versus a methadone clinic. The American Journal of Medicine. 105: 100-5. PMID 9727815 DOI: 10.1016/S0002-9343(98)00194-6  0.6
1998 Kosten TR, Cheeves C, Palumbo J, Seibyl JP, Price LH, Woods SW. Regional cerebral blood flow during acute and chronic abstinence from combined cocaine-alcohol abuse. Drug and Alcohol Dependence. 50: 187-95. PMID 9649971 DOI: 10.1016/S0376-8716(98)00038-6  0.6
1998 Oliveto AH, Rosen MI, Kosten TA, Hameedi FA, Woods SW, Kosten TR. Hydromorphone-naloxone combinations in opioid-dependent humans under a naloxone novel-response discrimination procedure. Experimental and Clinical Psychopharmacology. 6: 169-78. PMID 9608349 DOI: 10.1037/1064-1297.6.2.169  0.6
1998 Bowers MB, Malison RT, Seibyl JP, Kosten TR. Plasma homovanillic acid and the dopamine transporter during cocaine withdrawal. Biological Psychiatry. 43: 278-81. PMID 9513737 DOI: 10.1016/S0006-3223(97)00293-X  0.6
1998 Markou A, Kosten TR, Koob GF. Neurobiological similarities in depression and drug dependence: a self-medication hypothesis. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 18: 135-74. PMID 9471114 DOI: 10.1016/S0893-133X(97)00113-9  0.6
1997 Kosten TR, Rosen MI, McMahon TL, Bridge TP, O'Malley SS, Pearsall R, O'Connor PG. Treatment of early AIDS dementia in intravenous drug users: high versus low dose peptide T. The American Journal of Drug and Alcohol Abuse. 23: 543-53. PMID 9366972  0.44
1997 Schottenfeld RS, Pakes JR, Oliveto A, Ziedonis D, Kosten TR. Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse. Archives of General Psychiatry. 54: 713-20. PMID 9283506  0.6
1997 Rosen MI, Pearsall HR, Woods SW, Kosten TR. Effects of gamma-hydroxybutyric acid (GHB) in opioid-dependent patients. Journal of Substance Abuse Treatment. 14: 149-54. PMID 9258859 DOI: 10.1016/S0740-5472(96)00157-2  0.6
1997 Hameedi FA, Woods SW, Rosen MI, Pearsall HR, Kosten TR. Dose dependent effects of yohimbine on methadone maintained patients. The American Journal of Drug and Alcohol Abuse. 23: 327-33. PMID 9143642  0.6
1997 van Dyck CH, McMahon TJ, Rosen MI, O'Malley SS, O'Connor PG, Lin CH, Pearsall HR, Woods SW, Kosten TR. Sustained-release methylphenidate for cognitive impairment in HIV-1-infected drug abusers: a pilot study. The Journal of Neuropsychiatry and Clinical Neurosciences. 9: 29-36. PMID 9017526  0.6
1996 Wallace EA, Wisniewski G, Zubal G, vanDyck CH, Pfau SE, Smith EO, Rosen MI, Sullivan MC, Woods SW, Kosten TR. Acute cocaine effects on absolute cerebral blood flow. Psychopharmacology. 128: 17-20. PMID 8944401 DOI: 10.1007/s002130050104  0.6
1996 O'Connor PG, Oliveto AH, Shi JM, Triffleman E, Carroll KM, Kosten TR, Rounsaville BJ. A pilot study of primary-care-based buprenorphine maintenance for heroin dependence. The American Journal of Drug and Alcohol Abuse. 22: 523-31. PMID 8911590  0.6
1996 Rosen MI, Pearsall HR, Woods SW, Kosten TR. The effect of gamma-hydroxybutyric acid on naloxone-precipitated opiate withdrawal. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 14: 187-93. PMID 8866702 DOI: 10.1016/0893-133X(95)00087-T  0.6
1996 Rosen MI, McMahon TJ, Woods SW, Pearsall HR, Kosten TR. A pilot study of dextromethorphan in naloxone-precipitated opiate withdrawal. European Journal of Pharmacology. 307: 251-7. PMID 8836612 DOI: 10.1016/0014-2999(96)00249-X  0.6
Show low-probability matches.